NEW YORK (GenomeWeb News) – Genomic Health yesterday reported more than double-digit growth in its fourth-quarter revenues fueled by increasing adoption of its Oncotype DX breast cancer recurrence test.
 
Revenues for the quarter ended Dec. 31, 2007, grew by 124 percent to $19.3 million from $8.6 million in the fourth quarter of 2006.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.